NCT03913676

Disseminating a Waitlist Treatment for Anxiety With Velibra

Terminated NA Last updated 12 November 2020

What this trial tests

NA trial testing Velibra in Anxiety in 11 participants. Terminated before completion.

Timeline

5 November 2019

Primary endpoint
2 March 2020

2 March 2020

Quick facts

Lead sponsor	University of Texas at Austin
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	11
Start date	5 November 2019
Primary completion	2 March 2020
Estimated completion	2 March 2020
Sites	1 location across United States

Drugs / interventions tested

• Velibra

Conditions studied

• Anxiety — all drugs for Anxiety →

Sponsor

University of Texas at Austin

Who can join

18 and older, any sex, with Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cognitive Behavioral Therapy (CBT) is a gold standard treatment for a wide spectrum of anxiety-related concerns. However, long waitlist times can serve as a substantial barrier to those seeking treatment. Internet delivered psychotherapy, such as internet-based CBT (I-CBT) may present an affordable option for disseminating empirically supported treatments. Velibra, an web-based I-CBT intervention, has shown initial promise in treating anxiety disorders.

Velibra has been used to treat anxiety-related disorders in European samples with participants recruited from general practitioner's offices and diagnosed with a specific subset of anxiety disorders. While these effects are encouraging, additional research is needed toevaluate whether Velibra could be implemented in a community mental health clinic in the U.S. Specifically, if Velibra could be successfully implemented within the context of mental health clinic waitlists, it may be capable of providing evidence-based treatment to larger groups of people at a faster rate than mental health clinics can structurally support.

The purpose of this study is to assess the feasibility of implementing Velibra into an American community clinic waitlist. We plan to offer free access to the Velibra program to members of the Anxiety and Stress Clinic (ASC) waitlist at the University of Texas at Austin experiencing anxiety. We will evaluate interest in the program, user data from the program, and opinions of the program post-completion. We hypothesize ASC patients will find utility in Velibra's ability to offer them mental health resources faster than the traditional waitlist can provide.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.